Clinical Trials · NCT05545800
Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Xiangya Hospital of Central South University
- Enrollment
- 78
- Start date
- Sep 2022
- Locations
- 1 site, China
- Primary endpoint
- Mean Change From Baseline in HbA1c